Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INSULIN LISPRO RECOMBINANT
- Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia
- A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
- Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes
- Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)
- SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
- Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
- Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes
- Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
- A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes
- A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes
- A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers
- A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
- Safety and Efficacy of BC LisPram
- A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)
- Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
- Human Versus Analogue Insulin in Patients After Pancreatectomy.
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
- A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus
- A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps
- PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males
- A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus
- The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.
- A Study of LY900014 in Healthy Chinese Participants
- Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients
- Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes
- Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec
- A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
- A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges
- The Bihormonal iLet Bionic Pancreas Feasibility Study
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
- A Study of LY900014 in a Medtronic Pump
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
- Simplified Insulin Regimen for the Elderly
- A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects
- A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects
- Collection of Breath and Sweat to Identify Indicators of Hypoglycemia
- A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
- Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
- Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients
- A Study of LY900014 in Participants With Type 1 Diabetes Mellitus
- A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus
- A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
- A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus
- Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
- Mylan Insulin Glargine Study
- A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
- "Physiological" Insulin Scheme vs Traditional Scheme for Glycemic Control in Non-critical Hospitalized Patients With Diabetes Mellitus 2
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus
- PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD
- A Study of LY900014 in Participants With Type 2 Diabetes Mellitus
- A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants
- Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
- A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants
- Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique
- Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes
- A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes
- A Study of LY900014 in Participants With Type 1 Diabetes
- A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump
- A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus
- 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus
- Environmental Effects Type 1 Diabetes Mellitus
- Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control
- A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
- Feasibility Trial Testing the Bionic Pancreas With ZP4207
- Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus
- A Study of LY900014 Formulation in Healthy Participants
- Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)
- A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
- A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM
- Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes
- Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes
- A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
- A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy
- A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
- A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
- Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.
- An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects
- A Study of Various Formulations of LY900014 in Healthy Participants
- A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
- A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy
- A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy
- Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion
- Insulin Dose Adjustments for Meals Differing in Fat Content in T1DM
- A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus
- A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®
- A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers
- To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus
- Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes
- Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus
- Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus
- Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus
- Glargine Versus NPH in Patients With Chronic Kidney Disease
- Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
- Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal
- Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine
- A Study of Lispro Formulations in Healthy Participants
- Normal Versus Dual Wave Insulin Bolus for High-protein Food
- A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes
- Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
- Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)
- A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1
- A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects W
- Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus
- A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics
- Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
- Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit
- A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements
- A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
- Regulation of Endogenous Glucose Production by Brain Insulin Action
- A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
- Linagliptin Inpatient Trial
- A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes
- A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants
- CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
- Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
- Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes
- The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
- Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations
- A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
- Comparison of Insulin Mix25 Versus Mix50
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
- Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation
- Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
- A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants
- Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
- Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
- Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes
- Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- A Study in Participants With Type 1 Diabetes Mellitus
- Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
- A Study in Participants With Type 2 Diabetes Mellitus
- A Study in Participants With Type I Diabetes Mellitus
- A Study in Adults With Type 1 Diabetes
- Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
- Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment
- Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes
- TAK-329 Glucose Clamp Study
- Efficacy of Insulin Lispro Mix 50/50 Therapy
- A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus
- Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes
- PK/PD Study of Intranasal Insulin in Type I Diabetes
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
- A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus
- Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
- Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
- Bioequivalence of Two Lispro Formulations
- To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy
- Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
- A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections
- A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro
- 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes
- A Study on the Effect of 2 Pen Devices on HbA1c
- A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone
- A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine
- A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients
- Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers
- A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
- Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type
- Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus
- Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone
- Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.
- Insulin Therapy in the Hospital Comparing Two Protocols
- A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial
- Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus
- Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20
- Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
- Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
- A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients
- Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast
- A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro
- Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
- Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
- Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes
- Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
- Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
- A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
- 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine
- Lispro Mix 25 vs. Glargine in Type 2 Diabetics
- A Study for Type 2 Diabetic Patients
- PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro
- 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellit
- Lyspro Insulin vs Regular Insulin in Cirrhotic Patients
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)
- Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
- Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
- Comparison of Insulins Aspart and Lispro in Insulin Pumps
- A Study for Patients With Type 1 Diabetes Mellitus
- Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
- Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
- A Study for Patients With Diabetes Mellitus (IOPA)
- Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)
- Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)
- A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
- Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
- Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes
- Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin
- Insulin Glargine in Type 2 Diabetes Mellitus
- Insulin Glulisine in Healthy Lean and Obese Subjects
- Insulin Glulisine in Type 2 Diabetes Mellitus
- Insulin Glulisine in Type 1 Diabetes Mellitus
- Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus
- The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
- Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin
- Local Registration Trial in China Humalog Mix 50
- Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
- Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
- Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
- Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes
- Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
- NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
- Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
- Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
- Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin
Clinical trials list
click for details